109334-93-2

Upstream product

• 109334-92-1 N-(benzyloxycarbonyl)melphalanylleucine tert-butyl ester 
• 148-82-3 L-PAM 
• 2748-02-9 L-leucine tert-butyl ester hydrochloride 
• 109334-91-0 N-(benzyloxycarbonyl)melphalan 

Downstream Products

• 109334-90-9 N,N-dibenzyltyrosyl-α-aminoisobutyryl-α-aminoisobutyrylmelphalanylleucine 
• 109334-88-5 N,N-dibenzyltyrosylglycylglycylmelphalanylleucine 
• 109334-89-6 N,N-diallyltyrosyl-α-aminoisobutyryl-α-aminoisobutyrylmelphalanylleucine 
• 109363-32-8 N,N-diallyltyrosylglycylglycylmelphalanylleucine 
• 109335-02-6 N,N-dibenzyl-O-tert-butyltyrosyl-α-aminoisobutyryl-α-aminoisobutyrylmelphalanylleucine tert-butyl ester 
• 109335-04-8 N,N-dibenzyl-O-tert-butyltyrosylglycylglycylmelphalanylleucine tert-butyl ester 
• 109335-01-5 N,N-diallyl-O-tert-butyltyrosyl-α-aminoisobutyryl-α-aminoisobutyrylmelphalanylleucine tert-butyl ester 
• 109334-95-4 N,N-diallyl-O-tert-butyltyrosylglycylglycylmelphalanylleucine tert-butyl ester 

Relevant academic research and scientific papers

Synthesis and evaluation of melphalan-containing N,N-dialkylenkephalin analogues as irreversible antagonists of the δ opioid receptor

N,N-Dialkylated leucine enkephalin analogues containing melphalan (Mel) in place of Phe4 were synthesized as potentially irreversible antagonists of the δ opioid receptor. These compounds, along with the corresponding Phe4 peptides,